ClinicalTrials.Veeva

Menu

Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation

K

Korea University

Status

Completed

Conditions

Atrial Fibrillation

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03479073
KUGH17098-001

Details and patient eligibility

About

To investigate the rate and risk factors of stroke or systemic embolism (SE) following atrial fibrillation (AF) ablation.

Full description

Since catheter ablation for AF reduces the burden of AF effectively, several studies have demonstrated that catheter ablation not only improves the quality of life but also reduces the risk of stroke and all cause mortality. However, until now the guideline has recommended the continuation of oral anticoagulation (OAC) therapy in patients who are at risk of stroke or systemic embolism (SE) based on the CHA2DS2-VASc score, even though they have sinus rhythm following catheter ablation. The aims of this retrospective study is to assess the rate of stroke/SE during follow-up period after AF ablation and identify the independent risk factors for stroke/SE in patients who underwent catheter ablation for AF.

Enrollment

3,198 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who underwent catheter ablation for AF

Exclusion criteria

  • None

Trial design

3,198 participants in 2 patient groups

Stroke group
Description:
Patients who experienced stroke or systemic embolic event following catheter ablation for AF.
Control group
Description:
Patients who did not experienced stroke or systemic embolic event following catheter ablation for AF.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems